Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients

被引:26
|
作者
Jouinot, Anne [1 ,2 ,3 ,4 ]
Ulmann, Guillaume [5 ,6 ]
Vazeille, Clara [1 ,2 ,3 ]
Durand, Jean-Philippe [1 ,2 ,3 ,6 ]
Boudou-Rouquette, Pascaline [1 ,2 ,3 ]
Arrondeau, Jennifer [1 ,2 ,3 ]
Tlemsani, Camille [1 ,2 ,3 ]
Fournel, Ludovic [7 ,8 ]
Alifano, Marco [7 ,8 ]
Wislez, Marie [9 ]
Chapron, Jeanne [9 ]
Le Bris, Camille [1 ,2 ,3 ]
Mansuet-Lupo, Audrey [10 ,11 ]
Damotte, Diane [10 ,11 ]
Neveux, Nathalie [5 ,6 ]
De Bandt, Jean-Pascal [5 ,6 ]
Alexandre, Jerome [1 ,2 ,3 ]
Cynober, Luc [5 ,6 ]
Goldwasser, Francois [1 ,2 ,3 ,6 ]
机构
[1] Paris Ctr Teaching Hosp, AP HP, Med Oncol Dept, Paris, France
[2] Canc Res PErsonalized Med CARPEM, Paris, France
[3] Paris Descartes Univ, USPC, Paris, France
[4] Paris Descartes Univ, Inst Cochin, CNRS UMR8104, INSERM U1016, Paris, France
[5] Paris Descartes Univ, Paris Ctr Teaching Hosp, AP HP, Clin Chem,USPC, Paris, France
[6] Paris Descartes Univ, Pharm Fac, USPC, EA PRETRAM 4466, Paris, France
[7] Paris Ctr Teaching Hosp, AP HP, Thorac Surg Dept, Paris, France
[8] Paris Descartes Univ, Paris, France
[9] Paris Descartes Univ, Paris Ctr Teaching Hosp, AP HP, USPC,Pneumol Dept, Paris, France
[10] Paris Ctr Teaching Hosp, AP HP, Pathol Dept, Paris, France
[11] Paris Descartes Univ, Ctr Rech Cordeliers, USPC, INSERM U1138, Paris, France
关键词
Resting energy expenditure; Malnutrition; Prognosis; Survival; Non-small cell lung cancer; RESTING ENERGY-EXPENDITURE; WEIGHT-LOSS; SKELETAL-MUSCLE; DIETARY-INTAKE; CACHEXIA; IMPACT;
D O I
10.1016/j.clnu.2019.08.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Metastatic non-small cell lung cancer (NSCLC) is the first cause of cancer death worldwide. Increased resting energy expenditure (REE) is frequent among cancer patients and may contribute to cancer cachexia. The aim of this study was to examine the prognostic value of increased REE in metastatic NSCLC patients. Methods: This observational study was conducted between June 2012 and November 2017 in the outpatient unit of the oncology department of Cochin hospital, Paris. Consecutive patients with newly diagnosed stage IV NSCLC underwent measurement of REE by indirect calorimetry before treatment initiation. Uni- and multivariate analysis of overall survival (OS, Cox models) included age, sex, smoking habit, histological subtype, performance status, body mass index, weight loss, albumin and CRP levels and the ratio of measured REE to the REE predicted by the Harris Benedict formula (mREE/pREE). Results: 144 patients were enrolled: mean age 64 years, 63% male, 90% non-squamous carcinoma, including 17% with ALK/EGFR alteration. In univariate analysis, tobacco consumption (p = 0.007), histomolecular subtype (p < 10(-3)), performance status (p = 0.04), weight loss (p < 10(-4)), albumin (p < 10(-4)), CRP (p = 0.001) and mREE/pREE ratio (>vs <= 120%: HR = 2.16, p < 10(-3)) were significant prognostic factors of OS. Median OS were 6.1 and 17.3 months in patients with mREE/pREE ratio > and <= 120%, respectively. In multivariate analysis, histomolecular subtype (non-squamous ALK/EGFR mutated vs squamous carcinoma: HR = 0.25, p = 0.006), weight loss (>vs <= 5%: HR = 1.98, p = 0.004), albumin (>= vs < 35 g/L: HR = 0.56, p = 0.02) and mREE/pREE ratio (> vs <= 120%: HR = 1.90, p = 0.004) were identified as independent prognostic factors. Conclusions: Elevated resting energy expenditure emerges as an independent prognostic factor in metastatic NSCLC. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:1893 / 1899
页数:7
相关论文
共 50 条
  • [21] HnRNPAB is an independent prognostic factor in non-small cell lung cancer and is involved in cell proliferation and metastasis
    Wang, Qinrong
    Gou, Xuanjing
    Liu, Lingling
    Zhang, Ting
    Yuan, Hang
    Zhao, Yan
    Xie, Yuan
    Zhou, Jianjiang
    Song, Kewei
    ONCOLOGY LETTERS, 2023, 25 (06)
  • [22] Loss of PTEN Expression is an Independent Poor Prognostic Factor in Non-small Cell Lung Cancer
    Yoo, Seol Bong
    Xu, Xianhua
    Lee, Hyun Ju
    Jheon, Sanghoon
    Lee, Choon-Taek
    Choe, Gheeyoung
    Chung, Jin-Haeng
    KOREAN JOURNAL OF PATHOLOGY, 2011, 45 (04) : 329 - 335
  • [23] Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer
    Lamy, Pierre-Jean
    Plassot, Carine
    Pujol, Jean-Louis
    PLOS ONE, 2015, 10 (06):
  • [24] METASTATIC LOCATIONS IN NON-SMALL CELL LUNG CANCER AND THEIR PROGNOSTIC SIGNIFICANCE
    Diaconescu, Razvan
    Payette, Genevieve
    Rodgers, Valerie
    Fortin, Bernard
    Lafond, Chantal
    Whittom, Renaud
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1280 - S1281
  • [25] Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer
    Pirl, William F.
    Traeger, Lara
    Greer, Joseph A.
    Jackson, Vicki
    Lennes, Inga T.
    Gallagher, Emily
    Sequist, Lecia
    Temel, Jennifer S.
    PALLIATIVE & SUPPORTIVE CARE, 2013, 11 (03) : 223 - 229
  • [26] Tumor Location Is Not an Independent Prognostic Factor in Early Stage Non-Small Cell Lung Cancer
    Puri, Varun
    Garg, Nitin
    Engelhardt, Erin E.
    Kreisel, Daniel
    Crabtree, Traves D.
    Meyers, Bryan F.
    Patterson, G. Alexander
    Krupnick, Alexander Sasha
    ANNALS OF THORACIC SURGERY, 2010, 89 (04): : 1053 - 1059
  • [27] Loss of PTEN Expression is an Independent Poor Prognostic Factor in Non-Small Cell Lung Cancer
    Yoo, Seol Bong
    Choe, Gheeyoung
    Xu, Xianhua
    Lee, Hyunju
    Jheon, Sanghoon
    Lee, Choon-Taek
    Chung, Jin-Haeng
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S392 - S392
  • [28] Malnutrition is an Independent Risk Factor on Survival on EGFR Mutated Patients Diagnosed with Non-Small Cell Lung Cancer
    De la Torre-Vallejo, Martha
    Luvian-Morales, Julissa
    Gonzalez-Ling, Ana
    Turcott, Jenny
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1413 - S1413
  • [29] Improving survival for patients with metastatic non-small cell lung cancer in the immunotherapy era
    Zhang, David
    Rohatgi, Anjali
    CANCER, 2025, 131 (01)
  • [30] Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients
    Shen, Hong
    Cao, Ying
    Li, Xiaofen
    Tan, Yinuo
    Chen, Jiaqi
    Yang, Ziru
    Kong, Yiyao
    Yuan, Ying
    MEDICINE, 2016, 95 (21)